[HTML][HTML] A review on extrahepatic manifestations of chronic hepatitis C virus infection and the impact of direct-acting antiviral therapy

C Mazzaro, L Quartuccio, LE Adinolfi, D Roccatello… - Viruses, 2021 - mdpi.com
Extrahepatic manifestations are a feature of chronic hepatitis C virus (HCV) infection. In the
course of chronic HCV infection, about 70% of patients have one or more extrahepatic …

Cryoglobulinaemia

D Roccatello, D Saadoun, M Ramos-Casals… - Nature Reviews …, 2018 - nature.com
Cryoglobulinaemia refers to the serum presence of cryoglobulins, which are defined as
immunoglobulins that precipitate at temperatures< 37° C. Type I cryoglobulinaemia consists …

[PDF][PDF] Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America recommendations for testing …

MG Ghany, TR Morgan… - …, 2020 - Wiley Online Library
HCV infection, risk-based screening failed to identify the majority of individuals with HCV
infection due to both clinician and patient barriers.(9-12) Analysis of the 2003-2010 National …

EASL recommendations on treatment of hepatitis C: final update of the series☆

JM Pawlotsky, F Negro, A Aghemo, M Berenguer… - Journal of …, 2020 - Elsevier
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …

EASL recommendations on treatment of hepatitis C 2016

European Association for The Study of The Liver - Journal of hepatology, 2017 - Elsevier
Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease
worldwide [1]. The long-term impact of HCV infection is highly variable, ranging from minimal …

Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection

Clinical infectious diseases, 2018 - academic.oup.com
Recognizing the importance of timely guidance regarding the rapidly evolving field of
hepatitis C management, the American Association for the Study of Liver Diseases (AASLD) …

[HTML][HTML] Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection

AIHCVG Panel - Clinical infectious diseases: an official publication …, 2018 - ncbi.nlm.nih.gov
Recognizing the importance of timely guidance regarding the rapidly evolving field of
hepatitis C management, the American Association for the Study of Liver Diseases (AASLD) …

EASL recommendations on treatment of hepatitis C 2018

JM Pawlotsky, F Negro, A Aghemo, M Berenguer… - Journal of …, 2018 - Elsevier
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …

Extrahepatic manifestations of chronic HCV infection

P Cacoub, D Saadoun - New England Journal of Medicine, 2021 - Mass Medical Soc
Extrahepatic Manifestations of Chronic HCV Infection Hepatitis C virus infection is
associated with nonhepatic diseases, including mixed cryoglobulinemic vasculitis, B-cell …

[PDF][PDF] Glycemic control predicts severity of hepatocyte ballooning and hepatic fibrosis in nonalcoholic fatty liver disease

AS Alexopoulos, MJ Crowley, Y Wang, CA Moylan… - …, 2021 - Wiley Online Library
Background and Aims Whether glycemic control, as opposed to diabetes status, is
associated with the severity of NAFLD is open for study. We aimed to evaluate whether …